Therapeutic potential of ReACp53 targeting mutant p53 protein in CRPC

被引：0
|
作者：
Yaqun Zhang
Lingfan Xu
Yan Chang
YanJing Li
William Butler
Er Jin
Aifen Wang
Yulei Tao
Xufeng Chen
Chaozhao Liang
Jiaoti Huang
机构：
[1] Beijing Hospital,Department of Urology
[2] National Center of Gerontology,Department of Pathology
[3] Duke University Medicine,Department of Urology
[4] the First Affiliated Hospital of Anhui Medical University,Institute of Clinical Pharmascology
[5] Anhui Medical University,Department of Respiratory Medicine
[6] Hangzhou First People’s Hospital,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2020年 / 23卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：160 / 171
页数：11
相关论文
共 50 条
  • [41] Reactivation of mutant p53 by an adaptor protein
    Roth, JC
    Lenz-Stoeppler, C
    Contente, A
    Dobbelstein, M
    GASTROENTEROLOGY, 2001, 120 (05) : A293 - A293
  • [42] Structural and Drug Targeting Insights on Mutant p53
    Gomes, Ana Sara
    Ramos, Helena
    Inga, Alberto
    Sousa, Emilia
    Saraiva, Lucilia
    CANCERS, 2021, 13 (13)
  • [43] Targeting the P53 Protein for Cancer Therapies: The Translational Impact of P53 Research
    Levine, Arnold J.
    CANCER RESEARCH, 2022, 82 (03) : 362 - 364
  • [44] Pontin, a new mutant p53 binding protein, promotes gain-of-function of mutant p53
    Zhao, Yuhan
    Zhang, Cen
    Yue, Xuetian
    Li, Xiaoyan
    Liu, Juan
    Yu, Haiyang
    Yang, Qifeng
    Feng, Zhaohui
    Hu, Wenwei
    CANCER RESEARCH, 2015, 75
  • [45] Mutant p53 protein, master regulator of human malignancies: a report on the fifth Mutant p53 Workshop
    G Blandino
    W Deppert
    P Hainaut
    A Levine
    G Lozano
    M Olivier
    V Rotter
    K Wiman
    M Oren
    Cell Death & Differentiation, 2012, 19 : 180 - 183
  • [46] Mutant p53 protein, master regulator of human malignancies: a report on the fifth Mutant p53 Workshop
    Blandino, G.
    Deppert, W.
    Hainaut, P.
    Levine, A.
    Lozano, G.
    Olivier, M.
    Rotter, V.
    Wiman, K.
    Oren, M.
    CELL DEATH AND DIFFERENTIATION, 2012, 19 (01): : 180 - 183
  • [47] Developing Therapeutic Strategies for CLL with Mutant p53
    Lee, Hun Ju
    Gallardo, Miguel
    Zhang, Xiaorui
    Ma, Huaxian
    Quintas-Cardama, Alfonso
    Qi, Yuan
    Su, Xiaoping
    Post, Sean M.
    BLOOD, 2015, 126 (23)
  • [48] GOF Mutant p53 in Cancers: A Therapeutic Challenge
    Dolma, Lobsang
    Muller, Patricia A. J.
    CANCERS, 2022, 14 (20)
  • [49] Targeting p53
    Madrid, LV
    SCIENTIST, 1999, 13 (04): : 14 - 14
  • [50] Advanced Strategies for Therapeutic Targeting of Wild-Type and Mutant p53 in Cancer
    Zhang, Shengliang
    Carlsen, Lindsey
    Hernandez Borrero, Liz
    Seyhan, Attila A.
    Tian, Xiaobing
    El-Deiry, Wafik S.
    BIOMOLECULES, 2022, 12 (04)
12345